Translational Development Acquisition Corp. Ordinary Shares (TDAC) is a publicly traded Financial Services sector company. As of July 27, 2026, TDAC trades at $10.87 with a market cap of $207.28M and a P/E ratio of 0.00. TDAC moved +0.05% today. Year to date, TDAC is +4.07%; over the trailing twelve months it is flat. Its 52-week range spans $10.00 to $10.80. Rallies surfaces TDAC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest TDAC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $10.87 |
| Market Cap | $207.28M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.80 |
| 52-Week Low | $10.00 |
| Volume | 6.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $6.36M |
| Gross Margin | 0.00% |
TDAC analyst coverage data. Average price target: $0.00.